carcinoma and expression in human clear cell renal cell Altered levels of acid, basic, and neutral peptidase

You might find this additional information useful... This article cites 34 articles, 13 of which you can access free at: http://ajprenal.physiology.org/cgi/content/full/292/2/F780#BIBL Updated information and services including high-resolution figures, can be found at: http://ajprenal.physiology.org/cgi/content/full/292/2/F780 Additional material and information about AJP - Renal Physiology can be found at: http://www.the-aps.org/publications/ajprenal This information is current as of February 6, 2007 . € American Physiological Society. ISSN: 0363-6127, ESSN: 1522-1466. Visit our website at http://www.the-aps.org/.

[1]  L. Tailleux,et al.  CD13/N-aminopeptidase is involved in the development of dendritic cells and macrophages from cord blood CD34(+) cells. , 2000, Blood.

[2]  L. Callado,et al.  Subcellular distribution of membrane-bound aminopeptidases in the human and rat brain , 2005, Neuroscience Letters.

[3]  M. Tatematsu,et al.  Decreases of Metallothionein and Aminopeptidase N in Renal Cancer Tissues1 , 2001, Journal of biochemistry.

[4]  G. Booz,et al.  Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy , 2004, Regulatory Peptides.

[5]  R. Motzer,et al.  Aminopeptidase A expression and enzymatic activity in primary human renal cancers. , 1998, International journal of oncology.

[6]  D. Riemann,et al.  Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP‐increasing mediators , 1998, Clinical and experimental immunology.

[7]  R. Fagard,et al.  Arginine-aminopeptidase in rat cardiac fibroblastic cells participates in angiotensin peptide turnover. , 2004, Cardiovascular research.

[8]  V. Botbol,et al.  Effects on Mammals of the Aminopeptidase Inhibitor Bestatin , 2004 .

[9]  R. Magnusson,et al.  Purification, Characterization, and Cloning of a Cytosolic Aspartyl Aminopeptidase* , 1998, The Journal of Biological Chemistry.

[10]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[11]  R Pasqualini,et al.  Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. , 2000, Cancer research.

[12]  I. Saiki,et al.  Inhibition of Tumor Cell Invasion by Ubenimex (Bestatin) in vitro , 1989, Japanese journal of cancer research : Gann.

[13]  L. Shapiro,et al.  The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis. , 2003, Blood.

[14]  F. Abe,et al.  Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines , 1999, Leukemia.

[15]  H. Itoh,et al.  Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. , 1993, The Journal of clinical investigation.

[16]  C. Teixeira,et al.  Representative aminopeptidases and prolyl endopeptidase from murine macrophages: comparative activity levels in resident and elicited cells. , 2005, Biochemical pharmacology.

[17]  P. Ward,et al.  Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. , 1990, The Journal of pharmacology and experimental therapeutics.

[18]  N. Bander,et al.  Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Masucci,et al.  Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II. , 2005, Cancer research.

[20]  P. F. Silveira,et al.  Renal and macrophage aminopeptidase activities in cyclosporin-treated mice. , 2006, International immunopharmacology.

[21]  U. Rebmann,et al.  Endopeptidase 24.11/CD10 is down-regulated in renal cell cancer. , 1998, International journal of molecular medicine.

[22]  A. Pessina,et al.  Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseases , 2002, Journal of hypertension.

[23]  S. Mizutani,et al.  Human Leukocyte-derived Arginine Aminopeptidase , 2003, Journal of Biological Chemistry.

[24]  M. Sim,et al.  Degradation of angiotensin I to [des-Asp1]angiotensin I by a novel aminopeptidase in the rat hypothalamus. , 1994, Biochemical pharmacology.

[25]  J. Martínez,et al.  Aminopeptidase activities in breast cancer tissue. , 1999, Clinical chemistry.

[26]  L. Shapiro,et al.  CD13/Aminopeptidase N in Tumor Growth and Angiogenesis , 2004 .

[27]  S. Fuhrman,et al.  Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.

[28]  K. Nishikawa,et al.  Augmentation of death ligand‐induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines , 2001, International journal of cancer.

[29]  L. Hersh,et al.  Puromycin-sensitive Aminopeptidase , 1995, The Journal of Biological Chemistry.

[30]  R. Re.  Implications of intracrine hormone action for physiology and medicine. , 2003, American journal of physiology. Heart and circulatory physiology.

[31]  T. Tsuruo,et al.  Role of aminopeptidase N (CD13) in tumor‐cell invasion and extracellular matrix degradation , 1993, International journal of cancer.

[32]  J. Mcdermott,et al.  Characterization of aminopeptidases in human kidney soluble fraction. , 1990, Clinica chimica acta; international journal of clinical chemistry.

[33]  M. Grujić,et al.  Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions , 2002, Cancer Letters.

[34]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[35]  W. Murphy,et al.  Tumors of the kidney, bladder, and related urinary structures , 2004 .

[36]  R. Mentlein,et al.  Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells , 1996, Peptides.

[37]  D. Mantle.  Comparison of soluble aminopeptidases in human cerebral cortex, skeletal muscle and kidney tissues. , 1992, Clinica chimica acta; international journal of clinical chemistry.